Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6829968 | Seizure | 2018 | 15 Pages |
Abstract
We conclude that KD can be utilised and is generally well tolerated in infants with severe epilepsies. In addition, our experience suggests efficacy with improved seizure frequency/severity in around 50% without adverse effects on developmental outcome.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Naila Ismayilova, Mary-Anne Leung, Ravi Kumar, Martin Smith, Ruth E. Williams,